688016 Shanghai Microport Endovascular Medtech(Group)Co.,Ltd.
Trading 03-27 13:07:54
93.79
+1.69
+1.83%
High
94.30
Low
91.00
Vol
1.45M
Open
92.00
D1 Closing
92.10
Amplitude
3.58%
Mkt Cap
11.54B
Tradable Cap
11.54B
Total Shares
123.00M
T/O
135.00M
T/O Rate
1.18%
Tradable Shares
123.00M
P/B
2.92
ROE
--
EPS
0.00
52wk High
--
52wk Low
--
P/E
--
Dividend
--
Div.Yield
--
ROA
--
Time
5D
D
W
M
Loading ...
News
New Post(s)
Profile
BRIEF-Microport Scientific Gives FY Outlook For Shanghai Microport Endovascular Medtech
Reuters · 01-20
BRIEF-Microport Scientific Gives FY Outlook For Shanghai Microport Endovascular Medtech
Shanghai MicroPort Endovascular MedTech Obtains Medical Device Registration for Catheter
MT Newswires Live · 2024-12-19
Shanghai MicroPort Endovascular MedTech Obtains Medical Device Registration for Catheter
Shanghai MicroPort Endovascular MedTech to Pay Up to 70 Million Yuan in Back Taxes
MT Newswires Live · 2024-12-03
Shanghai MicroPort Endovascular MedTech to Pay Up to 70 Million Yuan in Back Taxes
Microport Scientific - 9M REV for Shanghai Microport Endovascular Medtech (Group) RMB969.6 Mln
THOMSON REUTERS · 2024-10-29
Microport Scientific - 9M REV for Shanghai Microport Endovascular Medtech (Group) RMB969.6 Mln
MicroPort Endovascular MedTech Affiliates Get China Nod for Blood Vessel Repair Devices
MT Newswires Live · 2024-09-24
MicroPort Endovascular MedTech Affiliates Get China Nod for Blood Vessel Repair Devices
Load more
Introduction
Company Name.
上海微创心脉医疗科技(集团)股份有限公司
Industry:
专用设备制造业
Listing Date:
2019-07-22
Main Business:
上海微创心脉医疗科技(集团)股份有限公司主要从事主动脉及外周血管介入医疗器械的研发、生产和销售。主要产品为胸主动脉覆膜支架系统、腹主动脉覆膜支架系统、术中支架类、球囊类、支架类。公司自成立以来,一直深耕于主动脉及外周血管介入医疗器械领域,通过多年的经验积累,公司已发展成我国主动脉血管介入医疗器械的龙头企业。公司产品已进入全国约1900家医院,主动脉产品国内市场占有率已连续多年排名国产品牌第一。
Issue price:
46.23
Invest in Global Markets with Tiger Brokers!
Open App
{"stockData":{"symbol":"688016","market":"SH","secType":"STK","nameCN":"Shanghai Microport Endovascular Medtech(Group)Co.,Ltd.","latestPrice":93.79,"timestamp":1743052074000,"preClose":92.1,"halted":0,"volume":1453849,"delay":0,"changeRate":0.0183,"floatShares":123000000,"shares":123000000,"eps":5.3329,"marketStatus":"Trading","change":1.69,"latestTime":"03-27 13:07:54","open":92,"high":94.3,"low":91,"amount":135000000,"amplitude":0.0358,"askPrice":93.78,"askSize":8,"bidPrice":93.51,"bidSize":2,"shortable":0,"etf":0,"ttmEps":5.3329,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1743058800000},"marketStatusCode":2,"adr":0,"adjPreClose":92.1,"symbolType":"stock_kcb","openAndCloseTimeList":[[1743039000000,1743046200000],[1743051600000,1743058800000]],"highLimit":101.31,"lowLimit":82.89,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":123262117,"isCdr":false,"pbRate":2.92,"roa":"--","peRate":17.587054,"roe":"14.38%","epsLYR":6.81,"committee":-0.123288,"marketValue":11561000000,"turnoverRate":0.0118,"status":0,"floatMarketCap":11561000000},"requestUrl":"/m/hq/s/688016","defaultTab":"news","newsList":[{"id":"2504284405","title":"BRIEF-Microport Scientific Gives FY Outlook For Shanghai Microport Endovascular Medtech","url":"https://stock-news.laohu8.com/highlight/detail?id=2504284405","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504284405?lang=en_us&edition=full_marsco","pubTime":"2025-01-20 23:40","pubTimestamp":1737387624,"startTime":"0","endTime":"0","summary":"BRIEF-Microport Scientific Gives FY Outlook For Shanghai Microport Endovascular MedtechJan 20 - Microport Scientific Corp 0853.HK:MICROPORT SCIENTIFIC SEES REVENUE OF SHANGHAI MICROPORT ENDOVASCULAR MEDTECH FOR YEAR BETWEEN RMB1,187.5 MILLION & RMB1,306.0 MILLIONMICROPORT SCIENTIFIC SEES NET PROFIT ATTRIBUTABLE OF SHANGHAI MICROPORT ENDOVASCULAR MEDTECH RMB492.5 MILLION TO RMB541.0 MILLION FOR YEARFurther company coverage: 0853.HK ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250120:nFWN3OG0JU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","BK1583","BK1100","00853","BK0251","BK1585","688016"],"gpt_icon":0},{"id":"2492114957","title":"Shanghai MicroPort Endovascular MedTech Obtains Medical Device Registration for Catheter","url":"https://stock-news.laohu8.com/highlight/detail?id=2492114957","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492114957?lang=en_us&edition=full_marsco","pubTime":"2024-12-19 14:55","pubTimestamp":1734591317,"startTime":"0","endTime":"0","summary":"Shanghai MicroPort Endovascular MedTech subsidiary Shanghai Lanmai Medical Technology registered its medical device with China's food and drug administrator.The registration of the peripheral balloon dilatation catheter is valid until Dec. 15, 2029, according to a Thursday filing with the Shanghai bourse.The catheter is suitable for the peripheral vascular system and for the treatment of obstructive lesions of autologous or artificial arteriovenous dialysis fistulas.Shares of the device maker were down 1% in recent trade.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0251","688016"],"gpt_icon":0},{"id":"2488967021","title":"Shanghai MicroPort Endovascular MedTech to Pay Up to 70 Million Yuan in Back Taxes","url":"https://stock-news.laohu8.com/highlight/detail?id=2488967021","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488967021?lang=en_us&edition=full_marsco","pubTime":"2024-12-03 16:22","pubTimestamp":1733214149,"startTime":"0","endTime":"0","summary":"Shanghai MicroPort Endovascular MedTech estimated back taxes of between 60 million yuan and 70 million yuan following the medical device manufacturer's disqualification from the high-tech enterprise.The back taxes are expected to account for more than 10% of the company's fiscal 2023 net profit, according to a Tuesday filing with the Shanghai bourse.Shares of Shanghai MicroPort Endovascular MedTech closed 3% Tuesday.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0251","688016"],"gpt_icon":0},{"id":"2479340240","title":"Microport Scientific - 9M REV for Shanghai Microport Endovascular Medtech (Group) RMB969.6 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2479340240","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479340240?lang=en_us&edition=full_marsco","pubTime":"2024-10-29 21:02","pubTimestamp":1730206951,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241029:nFWN3M51C0:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["688016","BK1585","BK1589","BK1100","BK0251","BK1583","00853"],"gpt_icon":0},{"id":"2469243702","title":"MicroPort Endovascular MedTech Affiliates Get China Nod for Blood Vessel Repair Devices","url":"https://stock-news.laohu8.com/highlight/detail?id=2469243702","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2469243702?lang=en_us&edition=full_marsco","pubTime":"2024-09-24 15:13","pubTimestamp":1727162001,"startTime":"0","endTime":"0","summary":"China's medical products administrator approved Shanghai MicroPort Endovascular MedTech's medical device registration for its fiber hair embolic coils, according to a Tuesday filing with the Shanghai Stock Exchange.Fiber hair embolic coils pack peripheral vascular aneurysms, arteriovenous malformations or abnormalities between arteries and veins in brain and spinal cord tissue, and arteriovenous fistulas or connections in the coverings of the brain or spinal cord.The regulator also accepted MicroPort Endovascular agent Veryan Medical's medical device registration for its peripheral stent system, which improves the lumen diameter of primary lesions in arteries, the filing said.Shares closed 5% higher in Shanghai during Tuesday's trading.Price : 84.12, Change: +4.3, Percent Change: +5.40%","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["688016","BK0251"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2019-07-22","address":"上海市浦东新区康新公路3399弄1号","stockEarnings":[{"period":"1week","weight":-0.0249},{"period":"1month","weight":-0.1317},{"period":"3month","weight":-0.2182},{"period":"6month","weight":-0.0148},{"period":"1year","weight":-0.1904},{"period":"ytd","weight":-0.1616}],"companyName":"上海微创心脉医疗科技(集团)股份有限公司","boardCode":"AI0035","perCapita":"7634股","boardName":"专用设备制造业","registeredCapital":"12326万元","compareEarnings":[{"period":"1week","weight":-0.0168},{"period":"1month","weight":-0.0013},{"period":"3month","weight":-0.0086},{"period":"6month","weight":0.0911},{"period":"1year","weight":0.1112},{"period":"ytd","weight":0.0051}],"survey":" 上海微创心脉医疗科技(集团)股份有限公司主要从事主动脉及外周血管介入医疗器械的研发、生产和销售。主要产品为胸主动脉覆膜支架系统、腹主动脉覆膜支架系统、术中支架类、球囊类、支架类。公司自成立以来,一直深耕于主动脉及外周血管介入医疗器械领域,通过多年的经验积累,公司已发展成我国主动脉血管介入医疗器械的龙头企业。公司产品已进入全国约1900家医院,主动脉产品国内市场占有率已连续多年排名国产品牌第一。","serverTime":1743052082161,"listedPrice":46.23,"stockholders":"16145人(较上一季度增加10.30%)","compareStock":{"symbol":"000001.SH","name":"SSE Comp"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.32.1","shortVersion":"4.32.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Shanghai Microport Endovascular Medtech(Group)Co.,Ltd.(688016),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Shanghai Microport Endovascular Medtech(Group)Co.,Ltd.(688016) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Shanghai Microport Endovascular Medtech(Group)Co.,Ltd.,688016,Shanghai Microport Endovascular Medtech(Group)Co.,Ltd.股票,Shanghai Microport Endovascular Medtech(Group)Co.,Ltd.股票老虎,Shanghai Microport Endovascular Medtech(Group)Co.,Ltd.股票老虎国际,Shanghai Microport Endovascular Medtech(Group)Co.,Ltd.行情,Shanghai Microport Endovascular Medtech(Group)Co.,Ltd.股票行情,Shanghai Microport Endovascular Medtech(Group)Co.,Ltd.股价,Shanghai Microport Endovascular Medtech(Group)Co.,Ltd.股市,Shanghai Microport Endovascular Medtech(Group)Co.,Ltd.股票价格,Shanghai Microport Endovascular Medtech(Group)Co.,Ltd.股票交易,Shanghai Microport Endovascular Medtech(Group)Co.,Ltd.股票购买,Shanghai Microport Endovascular Medtech(Group)Co.,Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Shanghai Microport Endovascular Medtech(Group)Co.,Ltd.(688016),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Shanghai Microport Endovascular Medtech(Group)Co.,Ltd.(688016) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}